Search clinical trials for: IL-1 beta

Total 71094 results

First Affiliated Hospital of Guangxi Medical University

Completed

Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder

NMO Spectrum Disorder | Azathioprine Adverse Reaction

China
Biocad

Completed

Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis (SOLAR)

Rheumatoid Arthritis

Russian Federation
Research Institute of Fundamental and Clinical...

Unknown

Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer (BC-LDC)

Breast Cancer
University of Pennsylvania

Recruiting

Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome

CRS - Cytokine Release Syndrome | HLH

United States
Priscilla Hsue, MD
Massachusetts General Hospital

Completed

Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk

Cardiovascular Disease | HIV

United States
Brigham and Women's Hospital
GlaxoSmithKline

Completed

Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome (MATOCSS)

Churg Strauss Syndrome

United States
University Hospital, Lille

Withdrawn

IL-33, Endocan and Endothelial Cells (IL-33)

Endothelial Cell

France
Il-Yang Pharm. Co., Ltd.

Not yet recruiting

Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics and Safety of Orally Administered Radotinib

Drug Kinetics

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Not yet recruiting

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants

Healthy
Il-Yang Pharm. Co., Ltd.

Active, not recruiting

Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)

Chronic Myeloid Leukemia, Chronic Phase

China
Il-Yang Pharm. Co., Ltd.

Completed

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Children

Healthy
Il-Yang Pharm. Co., Ltd.

Completed

Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer

Healthy
Il-Yang Pharm. Co., Ltd.

Completed

Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment

Peptic Ulcer

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety

Healthy | Pharmacokinetics | Pharmacodynamics | Ilaprazole

Canada
Il-Yang Pharm. Co., Ltd.

Completed

Efficacy Study of Ilaprazole to Treat Erosive Esophgitis

GERD | Erosive Esophagitis

Korea, Republic of
ASLAN Pharmaceuticals

Completed

Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis

United States, Australia, Singapore, India, Canada, New Zealand, Dominican Republic, Poland
IRCCS Centro Neurolesi "Bonino-Pulejo"

Completed

Improving Hand Motor Function After Stroke: Role of Robotics

It is Possible That Amadeo Will Guarantee a Greater Clinical Improvement as Compared to an Occupational Therapy Thanks to the Strengthening of Brain Plasticity

Italy
US Department of Veterans Affairs

Completed

Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)

Post-traumatic Stress Disorder

United States
China Medical University Hospital

Unknown

The Related Factors With Resilience in Caregivers Whose Child With Leukemia

Condition 1. Children With ALL Are Still Alive and the Age of 18 Years of Age. | Condition 2. Has Been Completed to Guide the Treatment Regimen Were in Remission. | Condition 3. Caregiver Can or Taiwanese Language Communicator.

Taiwan
National Cancer Institute (NCI)

Completed

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

Melanoma | Neoplasm Metastasis

United States
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia

United States, Canada
Orlando Health, Inc.
Forest Laboratories

Withdrawn

Ceftaroline in the Treatment of Bone and Joint Infections

Osteomyelitis | Joint Infections

United States
Eli Lilly and Company

Active, not recruiting

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Ulcerative Colitis

Spain, United States, China, Australia, Austria, Belgium, France, Italy, United Kingdom, Japan, Hungary, India, Serbia, Taiwan, Russian Federation, Canada, Korea, Republic of, Switzerland, Argentina, Israel, Latvia, Poland, Ukraine, D... and more
Andrew H Miller
National Cancer Institute (NCI)

Completed

Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy

Breast Cancer

United States
Agios Pharmaceuticals, Inc.

Completed

A Phase I Study of AG-348 in Healthy Volunteers (AG-348 SAD)

Healthy Volunteer

United States
Cancer Research UK

Terminated

AMG 319 in HPV Positive and Negative HNSCC

Human Papillomavirus (HPV) | Positive or Negative Head and Neck Squamous Cell Carcinoma (HNSCC) of the Hypopharynx, Oropharynx, Oral Cavity, Supraglottis or Larynx

United Kingdom
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Cancer Immunotherapy Trials Network (CITN)

Terminated

NT-I7 for Kaposi Sarcoma in Patients With or Without HIV

HIV Infection | Kaposi Sarcoma | AIDS-Related Kaposi Sarcoma

United States
University of Chicago

Terminated

Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
Hyunseok Kang, MD
NeoImmuneTech

Recruiting

NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery

Recurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Resectable Oropharyngeal Squamous Cell Carcinoma

United States
Korea University Anam Hospital

Recruiting

Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation (REVISE-AF)

Atrial Fibrillation | Anticoagulant Adverse Reaction

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Recruiting

A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs

Chronic Myeloid Leukemia, Chronic Phase | CML, Chronic Phase | CML, Refractory | CML - Philadelphia Chromosome

Turkey, Korea, Republic of, Russian Federation, Ukraine
Il-Yang Pharm. Co., Ltd.

Completed

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac

Drug Interaction Potentiation

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD

Non-erosive Reflux Disease

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults

Influenza, Human
Il-Yang Pharm. Co., Ltd.

Completed

Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection

Helicobacter Infections

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori

Helicobacter Infections

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Immunogenicity and Safety Study of Inactivated Split Influenza Vaccine' in Healthy Korean Male Subjects

Healthy

Korea, Republic of
Merck KGaA, Darmstadt, Germany

Completed

Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects

Psoriasis

Germany
Eskisehir Osmangazi University

Completed

Autologous Serum Skin Test and Serum IL-18 Levels in Chronic Idiopathic Urticaria and Respiratory Allergic Diseases

Urticaria | Respiratory Allergic Diseases

Turkey
Amgen

Completed

AMG 319 Lymphoid Malignancy FIH

Lymphoma | Leukemia | Cancer | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Hematologic Malignancies | Diffuse Large Cell Lymphoma | Oncology | Tumors | T Cell Lymphoma | Oncology Patients | Hematology | Low Grade Lymphoma

United States
Tehran University of Medical Sciences

Enrolling by invitation

The Assessment of the Effect of Vitamin D Supplementation on Inflammatory and Endothelial Factors in the Patients With Type 2 Diabetes .

Type2 Diabetes
US Department of Veterans Affairs

Withdrawn

Comparison of the Effect of Intense-Exercise/Moderate-Calorie, Topiramate-Phentermine and Cognitive Behavioral Therapy on Obesity

Obesity | Diabetes Mellitus

United States
Pfizer

Terminated

Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors

Renal Cell Carcinoma | Non-small-cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck | Urothelial Carcinoma | Colorectal Carcinoma | Ovarian Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | IDH2 Gene Mutation | Acute Bilineal Leukemia | Acute Biphenotypic Leukemia

United States
National Cancer Institute (NCI)

Completed

Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase

Melanoma | Neoplasm Metastasis

United States
HRH Pharmaceuticals Limited
GALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil and other collaborators

Completed

Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)

COVID-19

Brazil
Pieris Australia Pty Ltd

Completed

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma

Asthma

Australia
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Examining Changes in Nasal IL-1 During Acute Asthma Exacerbation in Adolescents (Attack Asthma)

Asthma

United States
Pusan National University Yangsan Hospital

Completed

Effects of Trunk Stabilization Training Device on Balance Ability for Stroke Patients

Stroke

Korea, Republic of
Yonsei University

Unknown

Novel Blood-based Colorectal Cancer Screening Method Using Natural Killer Cell Activity and Gene Panel Expression

Colorectal Cancer | Colorectal Adenoma

Korea, Republic of

Search clinical trials for: IL-1 beta

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations